-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Transformed Lymphoma - What Should I Do Now?

Program: Education Program
Session: Indolent Lymphomas: Answers to Smoldering Questions
Hematology Disease Topics & Pathways:
therapy sequence, Adult, Therapies, Combinations, Biological Processes, Study Population, Clinically relevant, immune mechanism, pathways
Sunday, December 6, 2020, 11:55 AM-12:00 PM

Sonali M. Smith, MD

Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

Disclosures: Smith: BMS: Consultancy; Karyopharm: Consultancy, Research Funding; Pharmacyclics: Research Funding; TG Therapeutics: Consultancy, Research Funding; Celgene: Consultancy, Research Funding; Janssen: Consultancy; Acerta: Research Funding; FortySeven: Research Funding; Genentech/Roche: Consultancy, Other: Support of parent study and funding of editorial support, Research Funding.

OffLabel Disclosure: I may discuss unapproved uses for approved agents or unapproved agents. I will disclose whenever this is the case.

See more of: Indolent Lymphomas: Answers to Smoldering Questions
See more of: Education Program
<< Previous Presentation | Next Presentation